What changed today in Regulatory: 1 new study
Every new official record on the Pharmacy, Compounding & Regulatory Intelligence desk since this morning, each linked to its primary source.
Automated from official records1 source1 min read
02 NPHLA Intelligence desk
Pharmacy, Compounding & Regulatory Intelligence
For pharmacies, 503A compounders, 503B outsourcing facilities and the professionals who rely on them: official actions from the FDA and other regulators, tracked as they happen — with the original records attached.
Archive
32 stories- All
- Regulatory Radar
- Compounding Watch
- FDA Watch
- State Watch
- Deadline Watch
- What This Means for Your Pharmacy
- What Changed Today
- Explainer
- Analysis
- Research brief
What changed today in Regulatory: 1 safety alert
Every new official record on the Pharmacy, Compounding & Regulatory Intelligence desk since this morning, each linked to its primary source.
Automated from official records3 sources1 min read
What changed today in Regulatory: 1 safety alert
Every new official record on the Pharmacy, Compounding & Regulatory Intelligence desk since this morning, each linked to its primary source.
Automated from official records2 sources1 min read
What changed today in Regulatory: 1 proposed rule, 1 safety alert
Every new official record on the Pharmacy, Compounding & Regulatory Intelligence desk since this morning, each linked to its primary source.
Automated from official records2 sources1 min read
What changed today in Regulatory: 1 recall record
Every new official record on the Pharmacy, Compounding & Regulatory Intelligence desk since this morning, each linked to its primary source.
Automated from official records4 sources1 min read
What changed today in Regulatory: 1 recall record
Every new official record on the Pharmacy, Compounding & Regulatory Intelligence desk since this morning, each linked to its primary source.
Automated from official records4 sources1 min read
What changed today in Regulatory: 2 safety alerts
Every new official record on the Pharmacy, Compounding & Regulatory Intelligence desk since this morning, each linked to its primary source.
Automated from official records4 sources1 min read
What changed today in Regulatory: 1 safety alert
Every new official record on the Pharmacy, Compounding & Regulatory Intelligence desk since this morning, each linked to its primary source.
Automated from official records1 source1 min read
What PBM reform proposals would change for pharmacies
Pharmacy benefit managers sit between drug manufacturers, health plans and pharmacies. Reform proposals target how PBMs are paid, how they reimburse pharmacies and what they must disclose. Here is what is already in force and what is only proposed.
AI-assisted · Editor reviewed4 sources2 min read
How a drug’s place on FDA’s shortage list changes the compounding rules
When FDA lists a drug as in shortage, some federal limits on compounding copies of that drug stop applying; when FDA resolves the shortage, they return. Here is how that works for 503A pharmacies and 503B outsourcing facilities.
AI-assisted · Editor reviewed6 sources2 min read
503A or 503B? How the two federal compounding pathways differ — and why it mattered for GLP-1 medicines
Federal law gives compounders two routes, with different rules on prescriptions, quality standards, oversight and copies of approved drugs. Here is how they compare, using GLP-1 compounding as the worked example.
AI-assisted · Editor reviewed6 sources3 min read
What changed today in Regulatory: 1 new study
Every new official record on the Pharmacy, Compounding & Regulatory Intelligence desk since this morning, each linked to its primary source.
Automated from official records1 source1 min read